Diabetic kidney disease in northwest Ethiopia: Prevalence and determinants among adults with type 2 diabetes
PLOS One · 2026
DOI: 10.1371/journal.pone.0343210 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Workagegnehu Hailu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetic Nephropathies. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: College of Medicine and Health Sciences, University of Gondar.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Diabetic kidney disease (DKD), mainly due to type 2 diabetes (T2DM) is the leading cause of end-stage kidney disease globally. However, DKD prevalence in sub-Saharan Africa, particularly Ethiopia, is underexplored, especially using reliable markers like quantified albuminuria and cystatin C based estimated glomerular equations (eGFR). This study aimed to assess DKD prevalence and associated factors using multiple diagnostic markers.
Methods
A cross-sectional study was conducted in adult T2DM patients at the University of Gondar Comprehensive Specialized Hospital using systematic random sampling. Data on socio-demographics and lab parameters were collected, with DKD diagnosed via eGFR and/or albuminuria (spot urine albumin-to-creatinine ratio and 24-hour collection). SPSS version 28 was used for data analysis, and factors were identified through multivariable logistic regression, with significance at 95% CI and p < 0.05.
Results
In a study of 204 T2DM patients (mean age 60.2 years; 57.4% female), the prevalence of DKD was 37.3% (95% CI: 30.6–44.3). Significant factors associated with DKD included urban residence (AOR = 0.278, p = 0.023), poor blood pressure control (AOR = 2.33, p = 0.016), poor glycemic control (AOR = 2.93, p = 0.007), and longer diabetes duration (AOR = 6.78, p < 0.0001).
Conclusion
This study shows a high prevalence of DKD in T2DM patients, mainly identified via albuminuria. Poor blood pressure control, inadequate glycemic control, and longer diabetes duration were significantly associated with DKD. Regular screening and improved glycemic and blood pressure control are essential to slow DKD progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Internal Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
- Department of Medical Biochemistry, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
- Department of Pharmacology, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
- The Kids Research Institute Australia, Nedlands, Western Australia, Australia.
- Medical School, the Uiniversity of Western Australia, Crawley, Western Australia, Australia.
- Department Epidemiology and Biostatistics, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
ORCID-Profile: Workagegnehu Hailu
Förderung
- College of Medicine and Health Sciences, University of Gondar
Zitieren
APA
Hailu, W., Dejene, T. A., Tiruneh, M., Molla, M. D., Birru, E. M., Alemu, S., & Awoke, T. (2026). Diabetic kidney disease in northwest Ethiopia: Prevalence and determinants among adults with type 2 diabetes. PLOS One. https://doi.org/10.1371/journal.pone.0343210
Vancouver
Hailu W, Dejene TA, Tiruneh M, Molla MD, Birru EM, Alemu S, et al. Diabetic kidney disease in northwest Ethiopia: Prevalence and determinants among adults with type 2 diabetes. PLOS One. 2026. doi:10.1371/journal.pone.0343210
BibTeX
@article{Hailu2026,
author = {Hailu, Workagegnehu and Dejene, Tadesse Asmamaw and Tiruneh, Markeshaw and Molla, Meseret Derbew and Birru, Eshetie Melese and Alemu, Shitaye and Awoke, Tadesse},
title = {Diabetic kidney disease in northwest Ethiopia: Prevalence and determinants among adults with type 2 diabetes},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0343210}
}
EUVIMED